Astrazeneca (AZN) Operating Margin (2006 - 2026)
Astrazeneca (AZN) operating margin from Mar 31, 2006 to Mar 31, 2026. The current Astrazeneca (AZN) operating margin is 27.77%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Astrazeneca (AZN)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 23.40% | +26.48% |
| 2024 | 18.50% | +3.44% |
| 2023 | 17.88% | +111.12% |
| 2022 | 8.47% | +200.15% |
| 2021 | 2.82% | -85.45% |
| 2020 | 19.39% | +61.73% |
| 2019 | 11.99% | -21.79% |
| 2018 | 15.33% | -6.32% |
| 2017 | 16.37% | -23.20% |
| 2016 | 21.31% | +27.99% |
| 2015 | 16.65% | +106.84% |
| 2014 | 8.05% | -44.04% |
| 2013 | 14.38% | -50.62% |
| 2012 | 29.13% | -23.53% |
| 2011 | 38.09% | +10.25% |
| 2010 | 34.55% | -1.82% |
| 2009 | 35.19% | +21.61% |
| 2008 | 28.94% | +5.67% |
| 2007 | 27.38% | -11.76% |
| 2006 | 31.03% | N/A |
Comparison Astrazeneca (AZN) operating margin with competitors
Astrazeneca (AZN) operating margin is 27.77%.
| Ticker | Name | Operating Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 61.57% | +121.69% |
| GILD | Gilead Sciences Inc | 37.16% | +33.80% |
| NVS | Novartis AG | 31.31% | +12.73% |
| AMGN | AMGEN Inc | 30.94% | +11.40% |
| GSK | GSK Plc | 30.06% | +8.23% |
| ABBV | Abbvie Inc | 26.60% | -4.22% |
| JNJ | Johnson & Johnson | 26.58% | -4.30% |
| SNY | Sanofi | 20.18% | -27.34% |
| OGN | Organon & Company | 18.22% | -34.40% |
| GRFS | Grifols SA | 14.65% | -47.25% |